Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Therapeutic Advances in Pulmonary and Critical Care Medicine is Scopus-indexed (Q3, CiteScore 2.6), WoS ESCI. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 2976-8675Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: About US$2,650 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 221 / 409 | 46th | Q3 |
| Pulmonary and Respiratory Medicine | 94 / 165 | 43rd | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2023–present, best quartile Q3, CiteScore 2.6.
Therapeutic Advances in Pulmonary and Critical Care Medicine is Q3 in Cardiology and Cardiovascular Medicine (rank 221 of 409) and Q3 in Pulmonary and Respiratory Medicine (rank 94 of 165), by CiteScore 2025.
Therapeutic Advances in Pulmonary and Critical Care Medicine is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.6, which places it in quartile Q3 at the 46th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.375, quartile Q3, with an H-index of 25.
The publisher lists an article processing charge of about US$2,650 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Therapeutic Advances in Pulmonary and Critical Care Medicine is published by SAGE Publications Ltd. Its ISSN is 2976-8675.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Therapeutic Advances in Pulmonary and Critical Care Medicine has an h-index of 4 and a 2-year mean of 2.8 citations per paper (OpenAlex). Its Scopus CiteScore is 2.6, quartile Q3. On 2-year citations it ranks #75 of 398 Scopus journals in Cardiology and Cardiovascular Medicine.
Therapeutic Advances in Pulmonary and Critical Care Medicine published 9 papers in 2025; its busiest recent year was 2024 with 9. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 23 research articles (2023–2026), authors are most often from United States (44.2%), Iran (8.7%) and Chile (4.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.